Miyamoto; Michiko

Patent Applications and Registrations

Patent applications and USPTO patent grants for Miyamoto; Michiko.The latest application filed is for "modified human hepatitis c virus genomic rna that can be autonomously replicated".

Company Profile

0.8.6

Miyamoto; Michiko - Tokyo JP
Miyamoto; Michiko - Fuchu JP
Miyamoto; Michiko - Fuchu-shi JP

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Modified human hepatitis C virus genomic RNA that can be autonomously replicated Grant 9,175,269 - Wakita , et al. November 3, 2	2015-11-03
Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle Grant 8,460,912 - Wakita , et al. June 11, 2	2013-06-11
Modified human hepatitis C virus genomic RNA that can be autonomously replicated Grant 8,454,973 - Wakita , et al. June 4, 2	2013-06-04
Modified Human Hepatitis C Virus Genomic Rna That Can Be Autonomously Replicated App 20130115592 - WAKITA; Takaji ; et al.	2013-05-09
Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene Grant 8,022,197 - Wakita , et al. September 20, 2	2011-09-20
Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene Grant 7,790,448 - Wakita , et al. September 7, 2	2010-09-07
Nucleic acid construct containing full length genome of human hepatitis C virus, recombinant full length virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus particle App 20100047896 - Wakita; Takaji ; et al.	2010-02-25
Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle Grant 7,659,103 - Wakita , et al. February 9, 2	2010-02-09
Modified Human Hepatitis C Virus Genomic RNA That can be Autonomously Replicated App 20090176200 - Wakita; Takaji ; et al.	2009-07-09
Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene App 20090042181 - Wakita; Takaji ; et al.	2009-02-12
Nucleic Acid and Gene Derived from Novel HCV Strain and Replicon-Replicating Cell Using Said Gene App 20090035747 - Wakita; Takaji ; et al.	2009-02-05
Nucleic Acid Construct Containing Fulllength Genome of Human Hepatitis C Virus, Recombinant Fulllength Virus Genome-Replicating Cells Having the Nucleic Acid Construct Transferred Thereinto and Method of Producing Hepatitis C Virus Particle App 20080220019 - Wakita; Takaji ; et al.	2008-09-11

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.